Peptides of natural and synthetic source are compounds operating in a wide range of biological interactions. They play a key role in biotechnological applications as both therapeutic and diagnostic tools. They are easily synthesized thanks to solid-phase peptide devices where the amino acid sequence can be exactly selected at molecular levels, by tuning the basic units. Recently, peptides achieved resounding success in drug delivery and in nanomedicine smart applications. These applications are the most significant challenge of the last decades: they can selectively deliver drugs on only pathological tissues whilst saving the other districts of the body. This specific feature allows to reduce the drug side effects and to increase the drug efficacy. In this context, peptides based aggregates present many advantages including biocompatibility, high drug loading capacities, chemical diversity, specific targeting and stimuli responsive drug delivery. A dual behavior is observed: on the one hand they can fulfill a structural and bioactive role. In this review, we focus on the design and the characterization of drug delivery systems using peptide-based carriers; moreover, we will also highlight the peptide ability to self-assemble and to actively address nanosystems towards specific targets.

Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives / Tesauro, Diego; Accardo, Antonella; Diaferia, Carlo; Milano, Vittoria; Guillon, Jean; Ronga, Luisa; Rossi, Filomena. - In: MOLECULES. - ISSN 1420-3049. - 24:2(2019), p. 351. [10.3390/molecules24020351]

Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives

Tesauro, Diego
Conceptualization
;
Accardo, Antonella
Conceptualization
;
Diaferia, Carlo
Conceptualization
;
MILANO, VITTORIA
Data Curation
;
Ronga, Luisa
Data Curation
;
Rossi, Filomena
Conceptualization
2019

Abstract

Peptides of natural and synthetic source are compounds operating in a wide range of biological interactions. They play a key role in biotechnological applications as both therapeutic and diagnostic tools. They are easily synthesized thanks to solid-phase peptide devices where the amino acid sequence can be exactly selected at molecular levels, by tuning the basic units. Recently, peptides achieved resounding success in drug delivery and in nanomedicine smart applications. These applications are the most significant challenge of the last decades: they can selectively deliver drugs on only pathological tissues whilst saving the other districts of the body. This specific feature allows to reduce the drug side effects and to increase the drug efficacy. In this context, peptides based aggregates present many advantages including biocompatibility, high drug loading capacities, chemical diversity, specific targeting and stimuli responsive drug delivery. A dual behavior is observed: on the one hand they can fulfill a structural and bioactive role. In this review, we focus on the design and the characterization of drug delivery systems using peptide-based carriers; moreover, we will also highlight the peptide ability to self-assemble and to actively address nanosystems towards specific targets.
2019
Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives / Tesauro, Diego; Accardo, Antonella; Diaferia, Carlo; Milano, Vittoria; Guillon, Jean; Ronga, Luisa; Rossi, Filomena. - In: MOLECULES. - ISSN 1420-3049. - 24:2(2019), p. 351. [10.3390/molecules24020351]
File in questo prodotto:
File Dimensione Formato  
molecules-24-00351.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 2.29 MB
Formato Adobe PDF
2.29 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/732623
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 176
  • ???jsp.display-item.citation.isi??? 162
social impact